Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
This study aims to comprehensively evaluate extracellular vesicle (EV)-based biomarkers circulating in body fluids with significant prognostic value in breast cancer (BrCa).
Main Authors: | Ceran Serdar Ceyhan, Osmanlıoğlu Şeyma |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-10-01
|
Series: | Türk Biyokimya Dergisi |
Subjects: | |
Online Access: | https://doi.org/10.1515/tjb-2023-0142 |
Similar Items
-
The Biology of Exosomes in Breast Cancer Progression: Dissemination, Immune Evasion and Metastatic Colonization
by: Cinzia Giordano, et al.
Published: (2020-08-01) -
Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer
by: Mercedes Tkach, et al.
Published: (2022-07-01) -
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
by: Oana Baldasici, et al.
Published: (2022-08-01) -
Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment
by: Ming-Tsung Hsu, et al.
Published: (2022-01-01) -
Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review
by: Shahram Darabi, et al.
Published: (2024-03-01)